Allopurinol 300 MG

DRUG15 trials

Sponsors

Gilead Sciences, Ardea Biosciences, Inc., University of Roma La Sapienza, Oslo University Hospital, Jiangsu HengRui Medicine Co., Ltd.

Conditions

AKI - Acute Kidney InjuryAcute Lymphocytic LeukemiaAcute Myelogenous LeukemiaAscitesBiphenotypic Acute LeukemiaBurkitt LymphomaChronic Myelogenous LeukemiaCirrhosis

Phase 1

RDEA3170 and Allopurinol Combination Study in Gout Subjects

CompletedNCT02279641

Ardea Biosciences, Inc.Gout

Start: 2014-11-01End: 2015-09-11Updated: 2017-12-20

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

CompletedNCT02581553

Ardea Biosciences, Inc.Healthy

Start: 2015-10-31End: 2016-08-31Updated: 2016-12-19

Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence

CompletedNCT02888054

Ardea Biosciences, Inc.Healthy

Start: 2016-08-30End: 2017-02-01Updated: 2017-06-16

Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

CompletedNCT03272425

Ardea Biosciences, Inc.Gout

Start: 2017-08-14End: 2017-10-04Updated: 2018-11-07

Phase 2

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

CompletedNCT02063997

Gilead SciencesGout

Start: 2014-03-31End: 2015-01-31Updated: 2018-01-29

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

CompletedNCT02498652

Ardea Biosciences, Inc.Gout

Start: 2015-07-28End: 2016-06-02Updated: 2018-01-23

Lowering Uric Acid in Live Kidney Donors

CompletedNCT03353298

Oslo University HospitalRenal Transplant Donor of Left Kidney, Renal Transplant Donor of Right Kidney

Start: 2018-01-17End: 2020-09-25Updated: 2021-02-24

Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms

Ministry of Health, BrazilRefractory Angina

Start: 2021-03-03End: 2021-12-31Target: 40Updated: 2021-02-24

Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis

Tanta UniversityAscites, Cirrhosis, Hepatic Encephalopathy +2

Start: 2022-11-15End: 2025-01-30Target: 150Updated: 2023-04-13

Allopurinol to Prevent Cirrhosis Related Morbidities

CompletedNCT05545670

Tanta UniversityCirrhosis

Start: 2022-06-15End: 2023-03-01Updated: 2023-05-09

Allo HSCT Using RIC and PTCy for Hematological Diseases

RecruitingNCT05805605

Masonic Cancer Center, University of MinnesotaAcute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia +15

Start: 2023-05-01End: 2028-10-22Target: 56Updated: 2025-07-01

Allopurinol in Depression

Not yet recruitingNCT07574060

Tanta UniversityDepression

Start: 2026-05-20End: 2027-05-20Target: 70Updated: 2026-05-07

Phase 3

A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout

CompletedNCT04052932

Jiangsu HengRui Medicine Co., Ltd.Gout

Start: 2019-07-16End: 2021-07-14Updated: 2022-06-13

Phase 4

Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin

University of Roma La SapienzaDiabetes Mellitus Type 2 Platelets Reactivity Statin

Start: 2017-03-28End: 2017-07-15Target: 200Updated: 2017-06-22

Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients

Beni-Suef UniversityAKI - Acute Kidney Injury

Start: 2022-09-19End: 2025-09-30Target: 124Updated: 2023-01-19

Related Papers

Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study

RMD Open2018-02-0139 citations